pre-seed
Stage
1
Investors
About
PacingCure develops precision gene therapies targeting cardiac diseases caused by abnormal electrical properties, aiming to treat the root mechanisms of these conditions.
Explore PacingCure's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.